These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7441028)

  • 1. Approved drugs used in a nonapproved way.
    Kasik JE; Solomons G
    J Iowa Med Soc; 1980 Nov; 70(11):476-8. PubMed ID: 7441028
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of approved drugs in a nonapproved way.
    Kasik JE
    Iowa Med; 1987 Oct; 77(10):513-5. PubMed ID: 3679770
    [No Abstract]   [Full Text] [Related]  

  • 3. Point of law: what are the legal implications of prescribing and administering FDA-approved drugs in nonapproved ways?
    Kaunitz AM
    Hosp Med Staff; 1982 Feb; 11(2):15-8. PubMed ID: 10254209
    [No Abstract]   [Full Text] [Related]  

  • 4. Legal implications of preparing and dispensing approved drugs for unlabeled indications.
    Podell LB
    Am J Hosp Pharm; 1983 Jan; 40(1):111-3. PubMed ID: 6823981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific basis for nonapproved use of drugs in veterinary practice.
    Brumbaugh GW
    J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA extra-label restriction on drugs.
    Varney JE
    J Am Vet Med Assoc; 1983 Dec; 183(12):1372, 1374-5. PubMed ID: 6654717
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of human-label drugs in veterinary medicine.
    Reid JS
    J Am Vet Med Assoc; 1988 Jan; 192(2):247-9. PubMed ID: 3350756
    [No Abstract]   [Full Text] [Related]  

  • 8. American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.
    Pediatrics; 1970 Nov; 46(5):811-3. PubMed ID: 5536437
    [No Abstract]   [Full Text] [Related]  

  • 9. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informing patients about drugs: a wrong way and a right way.
    Woodson DW
    Med World News; 1979 Jun; 20(13):6. PubMed ID: 10242286
    [No Abstract]   [Full Text] [Related]  

  • 12. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

  • 13. Expiration dating of drugs under way.
    Cohn JP
    Am Pharm; 1980 Mar; NS20(3):10. PubMed ID: 7369125
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety-related drug labeling changes approved by FDA.
    White GG
    J Toxicol Clin Toxicol; 1998; 36(3):265-7. PubMed ID: 9678979
    [No Abstract]   [Full Text] [Related]  

  • 16. Professional drug labeling.
    Terry M
    J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
    [No Abstract]   [Full Text] [Related]  

  • 17. Sources of drug information: FDA-approved labeling and other official FDA sources.
    Lindstrom JA
    Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A perspective on drug reaction reporting.
    Schneller GH
    Am J Pharm Sci Support Public Health; 1974; 146(3):70-4. PubMed ID: 4850260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.